Corpus Intelligence IC Memo — ROCKCASTLE HOSPT. & RESPIR CARE CTR 2026-04-26 09:56 UTC
IC Memo — ROCKCASTLE HOSPT. & RESPIR CARE CTR
Investment Committee Memorandum | KY | 30 beds | Grade C | EBITDA uplift $5.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ROCKCASTLE HOSPT. & RESPIR CARE CTR

CCN 180115 | ROCKCASTLE, KY | 30 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ROCKCASTLE HOSPT. & RESPIR CARE CTR is a 30-bed suburban community hospital in ROCKCASTLE, KY with $79.1M in net patient revenue and a 2.2% operating margin. The hospital serves a payer mix of 34.7% Medicare, 5.6% Medicaid, and 59.7% commercial.

Thesis: Turnaround. Our ML models identify $5.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.2% to 9.6% (+736bps).

Net Revenue HCRIS$79.1M
Current EBITDA COMPUTED$1.7M
Operating Margin COMPUTED2.2%
Occupancy HCRIS35.1%
Revenue / Bed COMPUTED$2.6M
Net-to-Gross HCRIS37.4%
Distress Probability ML50.7%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
57
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 2.2% places it above the state median. Among 57 size-comparable peers (15-60 beds), the median margin is -3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (15-60), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ROCKCASTLE HOSPT. & RESPIR CAR (Target)KY30$79.1M2.2%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
CLARK REGIONAL MEDICAL CENTERKY54$156.4M16.5%
BAPTIST HEALTH RICHMONDKY53$145.6M-3.7%
FLAGET MEMORIAL HOSPITALKY40$86.2M-0.6%
ADVENTHEALTH MANCHESTERKY49$73.0M-11.0%
HARLAN ARHKY56$69.9M-24.1%
HARRISON MEMORIAL HOSPITALKY34$67.8M-9.9%
SAINT JOSEPH MOUNT STERLINGKY42$64.2M-5.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.7M+210bp18mo
Cost to Collect4.5%2.5%$1.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$962K+122bp9mo
Clean Claim Rate88.0%96.0%$51K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.7M
Cost to Collect
$1.6M
Denial Rate Reduction
$1.6M
A/R Days Reduction
$962K
Clean Claim Rate
$51K
Total EBITDA Uplift$5.8M
Current EBITDA$1.7M
+ RCM Uplift+$5.8M
Pro Forma EBITDA$7.6M
Current Margin2.2%
Pro Forma Margin9.6%
WC Released (1x)$3.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.7M$69.7M26.01x91.9%
Base (11x exit)10.0x11.0x$2.7M$77.5M28.94x96.0%
Bull Case9.0x11.0x$2.4M$97.6M40.48x109.6%
Bull (12x exit)9.0x12.0x$2.4M$107.2M44.46x113.6%
Bear Case11.0x10.0x$2.9M$39.7M13.48x68.2%
Bear (11x exit)11.0x11.0x$2.9M$44.7M15.15x72.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 15-60 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-11.0% / P50=-3.4% / P75=7.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.